Skip to content

Main Navigation

Latham BioPharm Group logo

978.266.9151
  • About Us
    • Who We Are / Mission and Values
    • Business Model / Value Proposition
    • Leadership Team
    • Consultants
  • Services
    • Non-dilutive Funding
      • Government Relations
      • Proposal Development
      • Post-award Support
      • Contract Compliance
    • Product Development
      • CMC
      • Regulatory
      • Clinical
      • Nonclinical
      • Discovery
      • Quality
      • Project Management
      • Vendor Management
    • Strategic Consulting
      • Strategic Planning
      • Financial Modeling
      • Market Research
      • Supply Chain Network Development & Optimization
      • Market Access / Launch
      • Due Diligence
      • Technology Scouting
  • Expertise
    • Product Types
      • Vaccines
      • Therapeutics
      • Small Molecules
      • Cell & Gene Therapies
      • Medical Devices
      • Diagnostics
      • Health IT
      • MCMs
      • Animal Health
    • Sectors
      • LBG Biologics
      • LBG Animal Health
      • LBG Pharma
      • LBG MD&D (Medical Devices, Diagnostics, and Health IT)
  • Media / Collateral
    • Press Releases
    • News
    • Events
    • Collateral
    • Case Studies
  • Careers
    • Working at LBG
    • Current Opportunities
  • Contact Us
    • Locations
    • Request a Meeting

Collateral

  • Press Releases
  • News
  • Events
  • Collateral
  • Case Studies

Collateral

Whitepaper

The Importance of ROI Evaluation in the Pharmaceutical/Biotechnology Industry

View Whitepaper
Whitepaper

Innovator Requirements for the Selection of a CAR-T CDMO

View Whitepaper
Whitepaper

Outsourcing Biosimilar Development, BioProcess International’s March 2017 Featured Report

View Whitepaper
Whitepaper

Manufacturing Economics: “Minimizing Costs and Process Times with Local Biomanufacturing”, June 2010, BioProcess International

View Whitepaper
Presentation

Biologics Drug Substance Manufacturing

View Presentation
Presentation

Emerging Techniques and Technologies

View Presentation
Whitepaper

“Single Use Becoming an Established Tool: Vendors’ Attention to Users’ Requirements and Familiarity Are Driving Increased Implementation”, May 15, 2010 (Vol. 30, No. 10), GEN|Genetic Engineering & Biotechnology News

View Whitepaper
Presentation

On Demand Product Development Teams

View Presentation
Whitepaper

“Manufacturing a Rapid Biologic Response”, Drug Development Research 70: 288-295, 2009

View Whitepaper

Interested in our services?

Contact us today to set up an appointment.

Get Started

Footer Navigation

  • About Us
  • Services
    • Non-dilutive Funding
    • Product Development
    • Strategic Consulting
  • Expertise
    • Product Types
    • Sectors
  • Media / Collateral
    • Press Releases
    • News
    • Events
    • Collateral
    • Case Studies
  • Careers
  • Contact Us

Contact Information

Follow Us
  • LinkedIn
Latham BioPharm Group
Phone: 978.266.9151
Email: Email Us

© Latham BioPharm Group. All rights reserved.